Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2026-01-01 @ 5:10 PM
Study NCT ID:
NCT01895361
Status:
COMPLETED
Last Update Posted:
2020-01-31
First Post:
2013-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
Sponsor:
Reprixys Pharmaceutical Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SelG1-00005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None